Fluidigm, DNA Software Ink Distribution Pact for CNV Analysis Product

Oct 04, 2018

|

NEW YORK (GenomeWeb) – Fluidigm said today that it has entered into a non-exclusive distribution agreement with DNA Software to provide that firm's CopyCount-CNV software for use with Fluidigm's Biomark HD system.

Biomark HD is an automated qPCR platform that uses microfluidics to detect CNVs in tens to hundreds of samples with significant cost and time savings over traditional plate‑based methods, according to Fluidigm.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

The Scan

Harder to Breathe

Researchers tie a variant in ADAMTS3 to breathing difficulties in dissimilar dog breeds, according to Discover's D-brief blog.

Sequence From the Jomon Period

The Japan Times reports that researchers sequenced the genome of a woman who lived during the Jomon period.

Shifting Sands of Gene Variant Interpretation

Parents of children with rare genetic disease have to contend with shifts in the interpretation of genetic variants, the Wall Street Journal reports.

This Week in Science

In Science this week: single-nucleus RNA sequencing of brain tissue from individuals with autism, and more.

Featured White Papers

Compatibility of liquid biopsy assays on multiple sequencing platforms

Epigenomic Analysis of Sorted Retinal Ganglion Cells using ATAC-seq

Cloning Bovine Immunoglobulin VH and VL Genes from Single B Cells

High-throughput Miniaturized Quantitative PCR with the Echo 525 Liquid Handler

May

22

Featured Webinar

A Digital PCR Liquid Biopsy Workflow for Mutation Detection and Therapeutic Monitoring

This webinar will outline the entire liquid biopsy workflow from cell-free DNA isolation to mutation detection by Crystal Digital PCR with the Naica System from Stilla Technologies.

Jun

11

Featured Webinar

The Promise of Liquid Biopsy in Lung Cancer Monitoring

This webinar will overview the potential for liquid biopsy approaches to monitor therapy resistance in lung cancer.

Jun

18

Featured Webinar

Clinical Genomics of NTRK Fusion Detection in Cancer

This webinar will discuss background and clinical genomics of NTRK fusion detection in cancer. NTRK fusions are the focus of new therapeutic options, but clonal and subclonal lesions are notoriously difficult to detect.

Jul

24

Featured Webinar

Comparison of Group B Streptococcus Molecular Assays for Routine Screening in Pregnant Women

This webinar will share the results of comparisons of commercially available nucleic acid amplification tests for use in routine screening of pregnant women for Group B Streptococcus (GBS).

Menu